Insulin Regular, Human
Brand name: Afrezza
Rank #137 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$119.4M
Total Cost
143,017
Total Claims
$119.4M
Total Cost
6,122
Prescribers
$835
Cost per Claim
11,248
Beneficiaries
204,345
30-Day Fills
$19K
Avg Cost/Provider
23
Avg Claims/Provider
Share of Medicare Part D Spending
0.04%
of total Medicare Part D spending
$119.4M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $119.4M total
🔎 Data Overview
Average cost of $10,611 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Insulin Regular, Human
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Kalpana Reddy | Endocrinology | Richmond Hill, NY | 311 | $844K |
| 2 | Anthony Giglio | Physician Assistant | Springfield, MO | 239 | $398K |
| 3 | Gary Becker | Internal Medicine | Brooklyn, NY | 114 | $393K |
| 4 | Bonnie Ferguson | Nurse Practitioner | Harold, KY | 280 | $374K |
| 5 | Iraklii Buziashvili | Endocrinology | Brooklyn, NY | 440 | $365K |
| 6 | Elizabeth Tape | Nurse Practitioner | Seymour, IN | 102 | $362K |
| 7 | Rhonda Solomon | Nurse Practitioner | Seneca Falls, NY | 202 | $332K |
| 8 | Anne Webster | Nurse Practitioner | Peoria, IL | 192 | $326K |
| 9 | Carrie Parrish Nyekan | Nurse Practitioner | Bowling Green, KY | 104 | $303K |
| 10 | Evelyn Runer | Endocrinology | Fairless Hills, PA | 147 | $298K |
| 11 | Mohammad Ijaz | Endocrinology | Zanesville, OH | 125 | $297K |
| 12 | Ilienis Perez-Rios | Physician Assistant | Alcoa, TN | 128 | $291K |
| 13 | Yousef Altowaireb | Endocrinology | Evansville, IN | 128 | $290K |
| 14 | Sindhu Igala | Endocrinology | Rowlett, TX | 209 | $286K |
| 15 | Heather Meeusen | Nurse Practitioner | Plymouth, WI | 31 | $278K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 134 | Olaparib (Lynparza) | $121.1M | 8,744 |
| 135 | Empagliflozin/Metformin Hcl (Synjardy Xr) | $119.7M | 121,366 |
| 136 | Edaravone (Radicava Ors) | $119.6M | 8,588 |
| 137 | Insulin Regular, Human (Afrezza) | $119.4M | 143,017 |
| 138 | Ezetimibe (Ezetimibe) | $118.1M | 2,859,001 |
| 139 | Ambrisentan (Ambrisentan) | $117.7M | 23,927 |
| 140 | Memantine Hcl (Memantine Hcl) | $117.5M | 2,268,098 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology